BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23808460)

  • 1. Clinical implications of current developments in genitourinary pathology.
    Zhou AG; Owens CL; Cosar EF; Jiang Z
    Arch Pathol Lab Med; 2013 Jul; 137(7):887-93. PubMed ID: 23808460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
    Peng D; Ge G; Xu Z; Ma Q; Shi Y; Zhou Y; Gong Y; Xiong G; Zhang C; He S; He Z; Li X; Ci W; Zhou L
    Epigenomics; 2018 Sep; 10(9):1189-1199. PubMed ID: 30182734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical Pitfalls in Genitourinary Pathology: 2018 Update.
    Cox RM; Magi-Galluzzi C; McKenney JK
    Adv Anat Pathol; 2018 Nov; 25(6):387-399. PubMed ID: 30157041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical Molecular Testing in a Clinical Genitourinary Service.
    Magers MJ; Cheng L
    Arch Pathol Lab Med; 2020 Mar; 144(3):277-289. PubMed ID: 31373513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple primary malignant neoplasms of the genitourinary system].
    Musierowicz A; Ryszkiewicz B; Labedzki A; Rogowski W; Molenda W; Kubicz Z
    Wiad Lek; 1985 Sep; 38(17):1213-6. PubMed ID: 4090494
    [No Abstract]   [Full Text] [Related]  

  • 6. The emerging role of extracellular vesicles as biomarkers for urogenital cancers.
    Nawaz M; Camussi G; Valadi H; Nazarenko I; Ekström K; Wang X; Principe S; Shah N; Ashraf NM; Fatima F; Neder L; Kislinger T
    Nat Rev Urol; 2014 Dec; 11(12):688-701. PubMed ID: 25403245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of synchronous triple primary carcinomas of the kidney, bladder and prostate].
    Satoh H; Momma T; Saito S; Hirose S
    Hinyokika Kiyo; 2003 May; 49(5):261-4. PubMed ID: 12822453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular diagnostics in urologic malignancies: a work in progress.
    Netto GJ
    Arch Pathol Lab Med; 2011 May; 135(5):610-21. PubMed ID: 21526959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel blood biomarkers of human urinary bladder cancer.
    Osman I; Bajorin DF; Sun TT; Zhong H; Douglas D; Scattergood J; Zheng R; Han M; Marshall KW; Liew CC
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3374-80. PubMed ID: 16740760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
    Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
    Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genitourinary cancers in older adults.
    Morganstern D; Garnick MB
    Clin Geriatr Med; 1998 May; 14(2):333-65. PubMed ID: 9536109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targetable gene fusions and aberrations in genitourinary oncology.
    Pederzoli F; Bandini M; Marandino L; Ali SM; Madison R; Chung J; Ross JS; Necchi A
    Nat Rev Urol; 2020 Nov; 17(11):613-625. PubMed ID: 33046892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genitourinary cancers].
    Mizuno R; Oya M
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():485-8. PubMed ID: 20979300
    [No Abstract]   [Full Text] [Related]  

  • 15. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genitourinary cancer in the elderly.
    Mulholland SG; Stefanelli JL
    Am J Kidney Dis; 1990 Oct; 16(4):324-8. PubMed ID: 2220779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applications of novel ERG immunohistochemistry in prostate cancer diagnosis and management.
    Shah RB
    Adv Anat Pathol; 2013 Mar; 20(2):117-24. PubMed ID: 23399797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?
    Netto GJ
    Adv Anat Pathol; 2013 May; 20(3):175-203. PubMed ID: 23574774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer.
    Cimadamore A; Gasparrini S; Santoni M; Cheng L; Lopez-Beltran A; Battelli N; Massari F; Giunchi F; Fiorentino M; Scarpelli M; Montironi R
    Expert Rev Mol Diagn; 2018 Jul; 18(7):645-655. PubMed ID: 29912582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on Geriatric Oncology Research presented at the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium.
    Shen J; Prentice M; Pollock Y; Franca M; Kanesvaran R
    J Geriatr Oncol; 2019 Jul; 10(4):523-525. PubMed ID: 30982753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.